DS-8895

DS-8895 is an anti-EphA2 monoclonal antibody. DS-8895 allows noninvasive measurement of EphA2 expresssion in tumors in vivo. DS-8895 can be studied in research for advanced solid cancers positive to EphA2[1][2].

DS-8895A

12352203

Ephrin Receptor

Protein Tyrosine Kinase/RTK

Cancer-Kinase/protease

Cancer

[1]Burvenich, I. J., et al., (2016) . Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 57 (6), 974–980. |[2]Giorgio, C., et al., (2020) . Ephrin or not? Six tough questions on Eph targeting. Expert opinion on therapeutic targets, 24 (5), 403–415.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P991577/

Inhibitory Antibodies

No Development Reported